TrialAdvances in therapy2020

Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses.

Xu Steven Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.